NCT04304547

Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-348 With Co-administration of CKD-828, D097 and D337 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Phase I clinical trial to compare the pharmacokinetics and safety of CKD-348 with co-administration of CKD-828, D097 and D337 in healthy adult volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	CKD-828, D097, D337, CKD-348 T1, CKD-348 T2	Subject of sequence A takes IP in the following order: 1. Each tablet of CKD-828 and D097 and D337 be taken at once 2. CKD-348 T1 1 tablet 3. CKD-348 T2 1 tabet
DRUG	CKD-348 T1, CKD-348 T2, CKD-828, D097, D337,	Subject of sequence B takes IP in the following order: 1. CKD-348 T1 1 tablet 2. CKD-348 T2 1 tablet 3. Each tablet of CKD-828 and D097 and D337 be taken at once
DRUG	CKD-348 T2, CKD-348 T1, CKD-828, D097, D337	Subject of sequence C takes IP in the following order: 1. CKD-348 T2 1 tablet 2. Each tablet of CKD-828 and D097 and D337 be taken at once 3. CKD-348 T1 1 tablet

Timeline

• Start date: 2020-02-04
• Primary completion: 2020-04-02
• Completion: 2020-04-02
• First posted: 2020-03-11
• Last updated: 2020-08-13

Locations

1 site across 1 country: South Korea